Pacira BioSciences [PCRX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison
Pacira BioSciences
NASDAQ
Loading...
Haleon Plc - ADR
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pacira BioSciences wins in 9 metrics, Haleon Plc - ADR wins in 10 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pacira BioSciences | Haleon Plc - ADR | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.14 | 19.89 | Pacira BioSciences |
| Price-to-Book Ratio | 1.47 | 5.07 | Pacira BioSciences |
| Debt-to-Equity Ratio | 83.32 | 53.41 | Haleon Plc - ADR |
| PEG Ratio | -0.10 | 21.31 | Pacira BioSciences |
| EV/EBITDA | 8.22 | 33.80 | Pacira BioSciences |
| Profit Margin (TTM) | -18.06% | 13.81% | Haleon Plc - ADR |
| Operating Margin (TTM) | 5.04% | 22.21% | Haleon Plc - ADR |
| EBITDA Margin (TTM) | 5.04% | 22.21% | Haleon Plc - ADR |
| Return on Equity | -15.57% | 9.38% | Haleon Plc - ADR |
| Return on Assets (TTM) | 2.69% | 4.61% | Haleon Plc - ADR |
| Free Cash Flow (TTM) | $178.75M | $2.67B | Haleon Plc - ADR |
| Dividend Yield | N/A | 1.63% | N/A |
| 1-Year Return | 45.62% | -12.24% | Pacira BioSciences |
| Price-to-Sales Ratio (TTM) | 1.58 | 3.62 | Pacira BioSciences |
| Enterprise Value | $1.30B | $119.36B | Haleon Plc - ADR |
| EV/Revenue Ratio | 1.84 | 8.05 | Pacira BioSciences |
| Gross Profit Margin (TTM) | 77.43% | 55.38% | Pacira BioSciences |
| Revenue per Share (TTM) | $15 | $2 | Pacira BioSciences |
| Earnings per Share (Diluted) | $-2.75 | $0.45 | Haleon Plc - ADR |
| Beta (Stock Volatility) | 0.41 | 0.23 | Haleon Plc - ADR |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Pacira BioSciences vs Haleon Plc - ADR Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pacira BioSciences | -1.05% | -8.34% | -11.67% | 1.72% | 3.10% | 28.86% |
| Haleon Plc - ADR | 0.34% | -1.67% | -9.45% | -13.10% | -4.85% | -6.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pacira BioSciences | 45.62% | -54.22% | -57.81% | -40.31% | 235.99% | 235.99% |
| Haleon Plc - ADR | -12.24% | 46.03% | 19.03% | 19.03% | 19.03% | 19.03% |
News Based Sentiment: Pacira BioSciences vs Haleon Plc - ADR
Pacira BioSciences
News based Sentiment: POSITIVE
Pacira BioSciences' decision to grant inducement awards to new employees signals confidence in future growth and a commitment to attracting top talent. The structured vesting schedules of both stock options and RSUs are designed to align employee interests with long-term shareholder value, which is a positive indicator for investors.
Haleon Plc - ADR
News sentiment data is not available for Haleon Plc - ADR at this time.
Performance & Financial Health Analysis: Pacira BioSciences vs Haleon Plc - ADR
| Metric | PCRX | HLN |
|---|---|---|
| Market Information | ||
| Market Cap | $1.12B | $41.44B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 417,955 | 8,861,440 |
| 90 Day Avg. Volume | 581,725 | 9,003,930 |
| Last Close | $23.62 | $8.82 |
| 52 Week Range | $15.16 - $27.64 | $8.71 - $11.42 |
| % from 52W High | -14.54% | -22.77% |
| All-Time High | $121.95 (Feb 23, 2015) | $11.42 (Jun 02, 2025) |
| % from All-Time High | -80.63% | -22.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | -0.01% |
| Quarterly Earnings Growth | 0.02% | 0.33% |
| Financial Health | ||
| Profit Margin (TTM) | -0.18% | 0.14% |
| Operating Margin (TTM) | 0.05% | 0.22% |
| Return on Equity (TTM) | -0.16% | 0.09% |
| Debt to Equity (MRQ) | 83.32 | 53.41 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.88 | $1.77 |
| Cash per Share (MRQ) | $9.92 | $0.08 |
| Operating Cash Flow (TTM) | $134.52M | $3.34B |
| Levered Free Cash Flow (TTM) | $108.49M | $2.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.63% |
| Last 12-Month Dividend | N/A | $0.17 |
Valuation & Enterprise Metrics Analysis: Pacira BioSciences vs Haleon Plc - ADR
| Metric | PCRX | HLN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.14 | 19.89 |
| Forward P/E | 8.20 | 21.31 |
| PEG Ratio | -0.10 | 21.31 |
| Price to Sales (TTM) | 1.58 | 3.62 |
| Price to Book (MRQ) | 1.47 | 5.07 |
| Market Capitalization | ||
| Market Capitalization | $1.12B | $41.44B |
| Enterprise Value | $1.30B | $119.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.84 | 8.05 |
| Enterprise to EBITDA | 8.22 | 33.80 |
| Risk & Other Metrics | ||
| Beta | 0.41 | 0.23 |
| Book Value per Share (MRQ) | $16.88 | $1.77 |
Financial Statements Comparison: Pacira BioSciences vs Haleon Plc - ADR
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PCRX | HLN |
|---|---|---|
| Revenue/Sales | $168.92M | $3.72B |
| Cost of Goods Sold | $34.31M | $1.66B |
| Gross Profit | $134.62M | $2.06B |
| Research & Development | $25.34M | $105.16M |
| Operating Income (EBIT) | $8.18M | $471.86M |
| EBITDA | $39.80M | $488.03M |
| Pre-Tax Income | $8.71M | $388.27M |
| Income Tax | $3.89M | $88.98M |
| Net Income (Profit) | $4.81M | $299.29M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PCRX | HLN |
|---|---|---|
| Cash & Equivalents | $283.61M | $911.36M |
| Total Current Assets | $759.96M | $5.59B |
| Total Current Liabilities | $314.73M | $6.42B |
| Long-Term Debt | $424.97M | $10.30B |
| Total Shareholders Equity | $798.54M | $21.57B |
| Retained Earnings | $-201.54M | $36.76B |
| Property, Plant & Equipment | $48.73M | $2.52B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PCRX | HLN |
|---|---|---|
| Operating Cash Flow | $37.87M | N/A |
| Capital Expenditures | $-8.55M | N/A |
| Free Cash Flow | $26.91M | N/A |
| Debt Repayment | $-2.81M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PCRX | HLN |
|---|---|---|
| Shares Short | 6.69M | 15.71M |
| Short Ratio | 10.25 | 1.93 |
| Short % of Float | 0.21% | 0.00% |
| Average Daily Volume (10 Day) | 417,955 | 8,861,440 |
| Average Daily Volume (90 Day) | 581,725 | 9,003,930 |
| Shares Outstanding | 46.24M | 12.27B |
| Float Shares | 39.82M | 8.99B |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 1.16% | 0.13% |
Dividend Analysis & Yield Comparison: Pacira BioSciences vs Haleon Plc - ADR
| Metric | PCRX | HLN |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.17 |
| Last 12-Month Dividend Yield | N/A | 1.63% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.91% |
| 3-Year Total Dividends | N/A | $0.34 |
| Ex-Dividend Date | N/A | Apr 25, 2025 |